---
figid: PMC4057133__not30306
figlink: /pmc/articles/PMC4057133/figure/NOT303F6/
number: Fig.Â 6
caption: Summary of signaling events leading to PRKD2-dependent induction of senescence
  in p53wt and p53mut GBM cells. RTK and/or GPCR signaling induces PKCs and downstream
  PRKD2 activation. Silencing of PRKD2 attenuates AKT activation (and MAPK activation
  in U87MG cells). In p53wt U87MG and primary GBM2 cells, this leads to increased
  p53, p21, and p27 expression. As a consequence, diminished cyclin-CDK activation,
  hypophosphorylation of pRb, and reduced transcription of E2F target genes induce
  senescence. In p53mut GM133 and Gli25 primary cells, PRKD2 silencing results in
  decreased AKT activation, upregulation of p15 and p27, G1/S arrest, and downregulated
  E2F1 transcription. Also this pathway induces senescence; however, the signaling
  modules downstream of p15 and p27 that are ultimately responsible for the induction
  of senescence remain to be elucidated.
pmcid: PMC4057133
papertitle: Silencing of protein kinase D2 induces glioma cell senescence via p53-dependent
  and -independent pathways.
reftext: Eva Bernhart, et al. Neuro Oncol. 2014 Jul;16(7):933-945.
pmc_ranked_result_index: '78737'
pathway_score: 0.9678517
filename: not30306.jpg
figtitle: Summary of signaling events leading to PRKD2-dependent induction of senescence
  in p53wt and p53mut GBM cells
year: '2014'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4057133__not30306.html
  '@type': Dataset
  description: Summary of signaling events leading to PRKD2-dependent induction of
    senescence in p53wt and p53mut GBM cells. RTK and/or GPCR signaling induces PKCs
    and downstream PRKD2 activation. Silencing of PRKD2 attenuates AKT activation
    (and MAPK activation in U87MG cells). In p53wt U87MG and primary GBM2 cells, this
    leads to increased p53, p21, and p27 expression. As a consequence, diminished
    cyclin-CDK activation, hypophosphorylation of pRb, and reduced transcription of
    E2F target genes induce senescence. In p53mut GM133 and Gli25 primary cells, PRKD2
    silencing results in decreased AKT activation, upregulation of p15 and p27, G1/S
    arrest, and downregulated E2F1 transcription. Also this pathway induces senescence;
    however, the signaling modules downstream of p15 and p27 that are ultimately responsible
    for the induction of senescence remain to be elucidated.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKD2
  - AKT3
  - CCNE2
  - PRKCZ
  - MAPK1
  - CDK4
  - CCND1
  - PRKCE
  - AKT2
  - PRKCI
  - PRKCQ
  - PRKCG
  - PRKCH
  - GNAS
  - MAPK3
  - MAPK14
  - GNAL
  - PRKCD
  - MAPK12
  - E2F1
  - CCNE1
  - PRKCA
  - CDK2
  - MAPK11
  - MAPK8
  - MAPK9
  - MAPK10
  - PRKCB
  - AKT1
  - NMUR1
  - PRKD3
  - MAPK13
  - Cancer
genes:
- word: PRKD2
  symbol: PRKD2
  source: hgnc_symbol
  hgnc_symbol: PRKD2
  entrez: '25865'
- word: MAPK/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: CyclinE
  symbol: Cyclin_E
  source: bioentities_symbol
  hgnc_symbol: CCNE2
  entrez: '9134'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: MAPK/AKT
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: CDK4
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: CyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: MAPK/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: G1/S
  symbol: Gs
  source: bioentities_symbol
  hgnc_symbol: GNAS
  entrez: '2778'
- word: MAPK/AKT
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK/AKT
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: G1/S
  symbol: Gs
  source: bioentities_symbol
  hgnc_symbol: GNAL
  entrez: '2774'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: MAPK/AKT
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: E2F1
  symbol: E2F1
  source: hgnc_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: CyclinE
  symbol: Cyclin_E
  source: bioentities_symbol
  hgnc_symbol: CCNE1
  entrez: '898'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: CDK2
  symbol: CDK2
  source: hgnc_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: MAPK/AKT
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK/AKT
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK/AKT
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK/AKT
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: MAPK/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: GPCR
  symbol: GPC-R
  source: hgnc_alias_symbol
  hgnc_symbol: NMUR1
  entrez: '10316'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: MAPK/AKT
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
